Panaxim (Cefuroxime sodium) produced by Laboratoires Panpharma of France

An antibacterial of the 2nd generation cephalosporin class

Indicated for the treatment of severe infections among adults, children and neonates including bacterial meningitis,
gonorrhea, in surgical prophylaxis, total hip replacement, sequential therapy in pneumonia and acute exacerbations
of chronic bronchitis (AECB).

Available in 750mg IM/IV powder for injection in box of 10s and 50s